ALYSON MANDEL: Open Payments
NPI 1821055518 · FALL RIVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,288 in 73 payments from 9 companies in 2025. Trend: 2023 $2,152 · 2024 $1,776 · 2025 $1,288
Food & beverage: $1,288
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 52 | $821 |
| Phathom Pharmaceuticals, Inc. | 7 | $127 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $126 |
| Lilly USA, LLC | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| GENZYME CORPORATION | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Celltrion USA Inc. | 1 | $25 |
Products named: RINVOQ, SKYRIZI, VOQUEZNA, ENTYVIO, CREON, DUPIXENT, OMVOH, OCALIVA.
Industry payments across MA — which companies pay providers there.
